SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.29 revenue of $3.4M August, 10 2023 05:43 PM Sonoma Pharmaceuticals Inc. 2023-08-10 17:43:58 ET Sonoma Pharmaceuticals press release ( NASDAQ: SNOA ): FQ1 GAAP EPS of -$0.29. Revenue of $3.4M (-15.0% Y/Y). Shares -0.09% AH. For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.29, revenue of $3.4M